Efficacy of Dexpanthenol in Thermic Erythema

NCT ID: NCT00839462

Last Updated: 2013-10-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study focuses to prove the equivalent efficacy of two different Dexpanthenol formulations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Erythema

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Thermal Erythema Dexpanthenol Erythema Efficacy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

Group Type EXPERIMENTAL

Dexpanthenol foam spray, new formulation

Intervention Type DRUG

2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter

Arm 2

Group Type ACTIVE_COMPARATOR

Dexpanthenol foam spray, old formulation

Intervention Type DRUG

2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexpanthenol foam spray, new formulation

2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter

Intervention Type DRUG

Dexpanthenol foam spray, old formulation

2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subjects
* Phototype: I to IV according to Fitzpatrick scale

Exclusion Criteria

* Pregnant or nursing women
* Subjects registered as being in exclusion period in the French Health Minister file of subjects
* Subjects with known allergy to cosmetics, skin care products, or topical drugs, a sensitivity related to any component of any formulations being tested
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bayer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bayer Study Director

Role: STUDY_DIRECTOR

Bayer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Villeurbanne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

12039

Identifier Type: -

Identifier Source: org_study_id